Top

Virchows Archiv

Published in:

01-08-2021 | Colorectal Cancer | Letter to the Editor

Tumor budding or tumor baloney?

Author: Sean M. Hacking

Published in: Virchows Archiv | Issue 2/2021

Excerpt

“For every complex problem there is an answer that is clear, simple, and wrong”

- H. L. Mencken

…

Zlobec I, Bächli M, Galuppini F, Berger MD, Dawson HE, Nagtegaal ID, Lugli A (2021) Refining the ITBCC tumor budding scoring system with a “zero-budding” category in colorectal cancer. Virchows Archiv. https://doi.org/10.1007/s00428-021-03090-wCrossRefPubMed

Koelzer VH, Zlobec I, Lugli A (2016) Tumor budding in colorectal cancer–ready for diagnostic practice? Hum Pathol 47:4–19CrossRef

Hacking SM, Chakraborty B, Nasim R, Vitkovski T, Thomas R (2021) A holistic appraisal of stromal differentiation in colorectal cancer: biology, histopathology, computation, and genomics. Pathol Res Pract 220:153378CrossRef

Calon A, Lonardo E, Berenguer-Llergo A, Espinet E, Hernando-Momblona X, Iglesias M, Sevillano M, Palomo-Ponce S, Tauriello DVF, Byrom D, Cortina C, Morral C, Barceló C, Tosi S, Riera A, Attolini CS-O, Rossell D, Sancho E, Batlle E (2015) Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nat Genet 47:320–329CrossRef

Beck AH, Sangoi AR, Leung S, Marinelli RJ, Nielsen TO, van de Vijver MJ, West RB, van de Rijn M, Koller D (2011) Systematic analysis of breast cancer morphology uncovers stromal features associated with survival. Sci Transl Med 3:108ra113CrossRef

Title: Tumor budding or tumor baloney?
Author: Sean M. Hacking
Publication date: 01-08-2021
Publisher: Springer Berlin Heidelberg
Keywords: Colorectal Cancer
Colorectal Cancer
Published in: Virchows Archiv / Issue 2/2021
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-021-03112-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Tumor budding or tumor baloney?

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2021

Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?

Insulitis in the pancreas of non-diabetic organ donors under age 25 years with multiple circulating autoantibodies against islet cell antigens

Histological interpretation of differentiated vulvar intraepithelial neoplasia (dVIN) remains challenging—observations from a bi-national ring-study

The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary

GATA3 is a useful immunohistochemical marker for distinguishing sarcomatoid malignant mesothelioma from lung sarcomatoid carcinoma and organizing pleuritis

Comparison of antemortem clinical diagnosis and post-mortem findings in intensive care unit patients